Nagesh Mhatre

Image

 

 

 

Nagesh S. Mhatre has over 35 years of senior management experience in international medical technology companies, including Miles Laboratories(Bayer, AG.) and Becton Dickinson & Company.  At Becton Dickinson, he served as corporate vice president and president of the company's Immunocytometry Systems Division. Becton Dickinson today is recognized as the leader in the Flow-Cytometry field worldwide.  Prior to this, he spent three years as President of Becton Dickinson Laboratory Products, Europe, in Grenoble, France.  At Miles Laboratories, he served four years in Rehovot, Israel as managing director of Miles-Yeda, a joint venture with the Weizmann Institute of Science.  Under Nagesh’s leadership, Miles-Yeda won an Outstanding Exporter of the State of Israel Award in 1973. 

 

Prior to joining the Halo Fund III Management Company, Nagesh has served in the initial development phases as Chairman and CEO (interim) of several startup companies: NuGenesis Technologies Corp., a company that developed and marketed data warehousing and data mining for pharmaceutical research groups; MicroSure, Inc., a medical device company; Strategic Solutions Group, an e-learning company, specializing in systems solutions for training and service for large corporations and US government agencies and Metrika, Inc., a developer of medical diagnostic technologies.   

 

Historically, he also served on the boards of Quidel Corporation, a medical diagnostic company, and NitroMed, Inc., a nitric oxide delivery systems for cardiac stenosis company. Nagesh was founding Chairman of Guava Technologies, Inc. which developed a flow metric system that is the first Personal Cytometer (Guava- PCA) for quantization in the bioanalytical field in human and veterinary sciences.  Currently, he serves as founding Chairman of BioImagene Corp, which recently acquired Scimagix, Inc., which he also founded.  He served as Executive Chairman of Alpha Innotech Corp., which provides integrated systems tools for functional genomics. He initiated two new startups – Cytoplex Biosciences, Inc., which explores chip technology for cell physiology, and Vista Biosciences, LLC, a developer of a novel continuous glucose monitoring system. 

 

In 2007, Nagesh joined The Halo Fund III Management Company as the Industry Consulting Partner for Medical Technologies.  He is also a member of The Angels’ Forum.  He serves as a Trustee on the Board of World Affairs Council, San Francisco.  He is a Charter Member and was membership chair (1998-1999) of Indus Entrepreneur-TiE Silicon Valley. He has been a member of the Boards of Governors of Silicon Valley Capital Club, Heidelberg International Club, San Francisco, CA. and Friends of Weizmann Institute of Science.  

 

Dr. Mhatre received his B.S. degree from Bombay University, India, an M.S. degree from Oregon State University and a Ph.D. degree in biochemistry/microbiology from Rutgers University, New Brunswick, N.J.